Levels of support
To improve clinical rehabilitation, we offer products with standardized protocols for treatment of movement disorders. We use advanced technologies which enable new ways to study balance and locomotion disorders. Together with leading clinics and scientists, Motekforce Link develops user-friendly, innovative, rehabilitation technology products.
OIM Orthopedie is with over 400 employees and 25 locations active throughout the Netherlands with high quality products and services, such as protheses, ortheses and orthopedic shoes. The primary goal is to be the best, fastest and most leading player in the orthopedic devices industry in The Netherlands. OIM Orthopedie has no profit goal and invests in scientific research.
Nutricia Advanced Medical Nutrition is a specialised business of Danone, focusses on pioneering nutritional discoveries that help people live healthier and longer lives. Nutricia aims to establish medical nutrition as an integral part of healthcare, expanding Danone’s mission to bring health through food to as many people as possible.
Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding € 1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its fields of expertise cover oncology, neurosciences and endocrinology.
Allergan is a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The company is anchored by strong and sustainable brand franchises, a premier pipeline, highly efficient operations and an experienced management team creating an un-rivaled foundation for long-term growth. Together, our Company is focused on developing new medicines that address unmet medical needs in critical therapeutic areas, as well as increasing global access to high-quality, affordable medicines. Driving continued innovation and growth is the combined company’s strong commitment to R&D, with an investment of ~$1.7 billion in 2015, focused on strategic development of innovative and durable value-enhancing products.
FIOR & GENTZ develops and distributes products for the orthotic field of orthopaedic technology. The company's main focus is on system joints for the production of orthoses and on therapeutic shoes. The company is not only dedicated to technology, but also to creating orthotic treatment concepts.